These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17536100)

  • 1. NRC final rule on expanded definition of byproduct material.
    J Nucl Med; 2007 Jun; 48(6):15N. PubMed ID: 17536100
    [No Abstract]   [Full Text] [Related]  

  • 2. Receipt of byproduct and special nuclear material--NRC. Final rule.
    Fed Regist; 1992 Oct; 57(204):47978-83. PubMed ID: 10121919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPA's proposed radionuclide emission standards stir up opposition.
    Tilyou SM
    J Nucl Med; 1989 Sep; 30(9):1435-9, 1442-3. PubMed ID: 2769402
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical use of byproduct material; proposed revision--NRC. Proposal rule.
    Fed Regist; 1998 Aug; 63(156):43516-80. PubMed ID: 10182573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical use of byproduct material; draft policy statement--NRC. draft policy statement.
    Fed Regist; 1998 Aug; 63(156):43580-6. PubMed ID: 10182574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive quality assurance in medical use and a standard of care--NRC. Advance notice of proposed rulemaking: withdrawal.
    Fed Regist; 1998 Dec; 63(231):66496. PubMed ID: 10338878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
    Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRC issues final rules on emergency access to LLRW sites.
    J Nucl Med; 1989 Jul; 30(7):1143. PubMed ID: 2738697
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiological protection policy for the disposal of radioactive waste. Adopted by the Commission in May 1997. The International Commission on Radiation Protection.
    Ann ICRP; 1997; 27 Suppl():1-21. PubMed ID: 9615859
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-level radioactive waste disposal needs industrial hygiene expertise.
    Leventhal L; Caesar G
    Occup Health Saf; 1989 Nov; 58(12):36-8. PubMed ID: 2594301
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive quality assurance in medical use and a standard of care; correction--NRC. Advance notice of proposed rulemaking: withdrawal; correction.
    Fed Regist; 1998 Dec; 63(240):69026. PubMed ID: 10338888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Air activation produced by high-energy medical accelerators.
    McGinley PH; White TA
    Med Phys; 1983; 10(6):796-800. PubMed ID: 6656693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licensing of radioactive materials in industry.
    Ely TS
    Arch Environ Health; 1970 Aug; 21(2):200-2. PubMed ID: 5430007
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomedical waste disposal--Nuclear Regulatory Commission. Final rule.
    Fed Regist; 1981 Mar; 46(47):16230-4. PubMed ID: 10250470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical issues in revision of radiation hazards prevention regulations of hospitals regarding radioactivation of medical accelerators; accompanying the revision of law concerning prevention from radiation hazards due to radioisotopes, etc., which come into force on April 1, 2012 in Japan].
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(8):1071-5. PubMed ID: 23133878
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current situation on developments of regulations for clearance of radioactive waste and byproduct materials regarding medical accelerators; the role of related academic societies and organizations in Japan].
    Watanabe H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2010 Jul; 66(7):829-32. PubMed ID: 20703005
    [No Abstract]   [Full Text] [Related]  

  • 17. Status and plans for implementation of NRC regulatory authority for certain naturally occurring and accelerator-produced radioactive material.
    Mauer A
    J Nucl Med Technol; 2007 Jun; 35(2):112-3. PubMed ID: 17537736
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
    Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In addition to the current byproduct materials, it is important that the nuclear regulatory commission take over regulation of naturally occurring and accelerator-produced radioactive materials. Against the proposition.
    Wilson JF
    Med Phys; 2006 Feb; 33(2):256-8. PubMed ID: 16532929
    [No Abstract]   [Full Text] [Related]  

  • 20. Revision of fee schedules; 100% fee recovery, FY 1992--NRC. Final rule.
    Fed Regist; 1992 Jul; 57(142):32691-721. PubMed ID: 10120254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.